The 3rd Annual Targeted Radiopharmaceuticals begins in:

Day
Hour
Minute
Second

Exploring the value of theragnostic radionuclide therapies
within advanced oncology

The 3rd Targeted Radiopharmaceuticals (TRP) Summit returns at a crucial time for the entire industry. Spurred on by positive Phase III VISION trial data, there has been huge research investment, on both sides of the Atlantic, on how to deliver radiation therapy directly and specifically to tumours.

For the 2021 edition of this conference, there will be the opportunity to attend either in-person in Berlin or remotely via a dedicated digital networking platform with all the access to the conference content.

You can expect a wider array of insights from recent case studies to help you accelerate the development of the next generation of radioligand therapies from clinical approval to commercialisation. 

As the only industry-led platform for discussing challenges and opportunities facing developers of theranostic radioligand therapies, we strive to tackle topics that are on every drug developer’s mind: 

  • How do we identify and validate new targets? 
  • Can we combine Targeted Radiopharmaceuticals with immunotherapy or other targeted oncology methods? 
  • How do we improve current clinical design methodologies and patient selection strategies? 
  • Where can improvements be made to the current supply and fulfilment models? 

To see the wide variety of talks, panels and speakers tackling these issues, download the full event guide here 

Expert Speakers Include:

What Past Attendees Have Said:

TR Sliders (5)

Proud to Partner With:

1NPS20-1291889__TargetedRadiopharmaceuticals_Logo_300
ITM_Logo_with_Claim
_LOGO_HORZ_RGB (002)
oncodesign_logotype_EN
1623144037088
IBA RadioPharma SCK CEN
LogPMB-01-CMJK
Screenshot 2021-07-20 085253
1588612391873
Minerva Imaging logo email signature
Ionetixlogo2021
EPS_Curium_Color_Logo_wtagline.eps
medpace 2
NorthStar Medical Radioiostopes, LLC logo Nov 2018 - no sub, transparent...
Logo_Chelatec
qt=q_95
eczacìbasì_monrol
logo
TRASIS-couleurs
logo_transparent
mim_logo_black

Health & Safety

The health, safety, and well-being of our community remains our highest priority. Therefore, all attendees will be required to complete a health declaration prior to attending the event. 

The German government is now applying the 2G rule. The 2G rule means that to attend the conference you will have to provide proof that you are fully vaccinated - learn more.

Therefore, in order to attend this conference, you will be required to show proof of vaccination.

Please note Hanson Wade will not accept proof of COVID19 recovery or a negative test result as a form of entry.

Your proof of vaccination must include the following data:

    • Personal information - at least surname, first name, and date of birth
    • Date of vaccination, number of vaccinations, and vaccine name
    • Name of the disease vaccinated against
    • Distinguishing marks that indicate which person or institution is responsible for performing the vaccination or issuing the certificate, such as an official emblem or the issuer’s name.

Additionally, you will be required to complete our mandatory Health Declaration before arriving onsite.

As part of this declaration, you will be asked to confirm you acknowledge and accept the mandate to provide proof of vaccination detailed above. Failure to provide this documentation will result in you being denied access to the event.

For further information about Health and Safety on site, please visit our FAQ here.